Gastrointestinal Cancer Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
RNXT | C | RenovoRx, Inc. | 6.60 | |
PMCB | F | PharmaCyte Biotech, Inc. | -2.86 |
Related Industries: Biotechnology
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
DFAC | A | Dimensional U.S. Core Equity 2 ETF | 0.0 | |
VTI | A | Vanguard Total Stock Market ETF | 0.0 | |
DFAT | A | Dimensional U.S. Targeted Value ETF | 0.0 | |
VXF | A | Vanguard Extended Market ETF | 0.0 |
Compare ETFs
- Gastrointestinal Cancer
Gastrointestinal cancer refers to malignant conditions of the gastrointestinal tract (GI tract) and accessory organs of digestion, including the esophagus, stomach, biliary system, pancreas, small intestine, large intestine, rectum and anus. The symptoms relate to the organ affected and can include obstruction (leading to difficulty swallowing or defecating), abnormal bleeding or other associated problems. The diagnosis often requires endoscopy, followed by biopsy of suspicious tissue. The treatment depends on the location of the tumor, as well as the type of cancer cell and whether it has invaded other tissues or spread elsewhere. These factors also determine the prognosis.
Overall, the GI tract and the accessory organs of digestion (pancreas, liver, gall bladder) are responsible for more cancers and more deaths from cancer than any other system in the body. There is significant geographic variation in the rates of different gastrointestinal cancers.
Recent Comments
- TraderMike on BOOT
- Dr_Duru on BOOT
- TraderMike on Stochastic Reached Oversold
- SuccessfulGrasshopper897 on Stochastic Reached Oversold
- Cos3 on Adding float as advanced filter criteria?
From the Blog
Featured Articles